Correction: UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

In this article (Clin Cancer Res 2017;23:1481–92), which was published in the March 15, 2017, issue of Clinical Cancer Research (1), a reader alerted us to labeling errors in Fig. 2, which were confirmed by the authors. In Fig. 2A and B, “500 nmol/L” should instead read “50 nmol/L.” The error was introduced during the production process and was not the fault of the authors. The author also informed us that units (nmol/L) for UNC2025 in Fig. 2C were mistakenly omitted during submission. The corrected version of Fig. 2 is provided below. The publisher and authors regret these errors.